Lv11
90 积分 2024-07-17 加入
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model-Based Assessments
2天前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
1个月前
已完结
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
2个月前
已完结
IFN-γ–resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models
2个月前
已完结
Secretion of a VEGF-blocking scFv enhances CAR T-cell potency
2个月前
已关闭
The best of both worlds: AAV-mediated gene transfer empowered by LNP delivery of Sleeping Beauty transposase for durable transgene expression in vivo
2个月前
已完结
In vivo CAR engineering for immunotherapy
2个月前
已完结
Engineering sonogenetic EchoBack-CAR T cells
4个月前
已完结
CD147-CAR-NK Cell Therapy Shows Minimal Toxicities in Human CD147 Transgenic Mouse Model with Solid Tumors
4个月前
已完结
Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies
5个月前
已完结
皖公网安备34019202002308
